Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AMLX | Amylyx Pharmaceuticals, Inc. | Co-Chief Executive Officer, Director | $10.3M | -$232K | -2.21% | Sep 30, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|